1155972005: Product containing precisely dacomitinib 30 milligram/1 each conventional release oral tablet (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual therapeutic moiety\Dacomitinib\Product containing only dacomitinib in oral dose form (medicinal product form)\Product containing precisely dacomitinib 30 milligram/1 each conventional release oral tablet (clinical drug)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Product containing protein-tyrosine kinase inhibitor\Product containing dacomitinib (medicinal product)\Product containing dacomitinib in oral dose form (medicinal product form)\Product containing only dacomitinib in oral dose form (medicinal product form)\Product containing precisely dacomitinib 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Product containing protein-tyrosine kinase inhibitor\Product containing dacomitinib (medicinal product)\Dacomitinib\Product containing only dacomitinib in oral dose form (medicinal product form)\Product containing precisely dacomitinib 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing dacomitinib (medicinal product)\Product containing dacomitinib in oral dose form (medicinal product form)\Product containing only dacomitinib in oral dose form (medicinal product form)\Product containing precisely dacomitinib 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing dacomitinib (medicinal product)\Dacomitinib\Product containing only dacomitinib in oral dose form (medicinal product form)\Product containing precisely dacomitinib 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing quinazoline\Product containing dacomitinib (medicinal product)\Product containing dacomitinib in oral dose form (medicinal product form)\Product containing only dacomitinib in oral dose form (medicinal product form)\Product containing precisely dacomitinib 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing quinazoline\Product containing dacomitinib (medicinal product)\Dacomitinib\Product containing only dacomitinib in oral dose form (medicinal product form)\Product containing precisely dacomitinib 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing dacomitinib (medicinal product)\Product containing dacomitinib in oral dose form (medicinal product form)\Product containing only dacomitinib in oral dose form (medicinal product form)\Product containing precisely dacomitinib 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing dacomitinib (medicinal product)\Dacomitinib\Product containing only dacomitinib in oral dose form (medicinal product form)\Product containing precisely dacomitinib 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product\Product manufactured as oral dose form\Product containing dacomitinib in oral dose form (medicinal product form)\Product containing only dacomitinib in oral dose form (medicinal product form)\Product containing precisely dacomitinib 30 milligram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2021. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

4571026017 Dacomitinib 30 mg oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module

4571951019 Product containing precisely dacomitinib 30 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing precisely dacomitinib 30 milligram/1 each conventional release oral tablet (clinical drug)	Plays role	Antineoplastic therapeutic role	true	Inferred relationship	Existential restriction modifier
Product containing precisely dacomitinib 30 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	Tablet	true	Inferred relationship	Existential restriction modifier
Product containing precisely dacomitinib 30 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	Dacomitinib	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely dacomitinib 30 milligram/1 each conventional release oral tablet (clinical drug)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Product containing precisely dacomitinib 30 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	Tablet	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely dacomitinib 30 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance	Dacomitinib	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely dacomitinib 30 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely dacomitinib 30 milligram/1 each conventional release oral tablet (clinical drug)	Is a	Product containing only dacomitinib in oral dose form (medicinal product form)	true	Inferred relationship	Existential restriction modifier

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
4571026017	Dacomitinib 30 mg oral tablet	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module
4571951019	Product containing precisely dacomitinib 30 milligram/1 each conventional release oral tablet (clinical drug)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module